Structure-Based Design of a Novel Series of Potent, Selective Inhibitors of the Class I Phosphatidylinositol 3-KinasesAdrian L. Smith, Mark H. Norman, Noel D. D’Angelo et al.|Journal of Medicinal Chemistry|2012Cited by 50
Selective Class I Phosphoinositide 3-Kinase Inhibitors: Optimization of a Series of Pyridyltriazines Leading to the Identification of a Clinical Candidate, AMG 511Mark H. Norman, Paul E. Hughes, Bradley J. Herberich et al.|Journal of Medicinal Chemistry|2012Cited by 50
Cytochrome P450-Mediated Epoxidation of 2-Aminothiazole-Based AKT Inhibitors: Identification of Novel GSH Adducts and Reduction of Metabolic Activation through Structural Changes Guided by in Silico and in Vitro ScreeningRaju Subramanian, Chun Li, Matthew R. Lee et al.|Chemical Research in Toxicology|2010Cited by 30
Phosphoinositide-3-kinase inhibitors: Evaluation of substituted alcohols as replacements for the piperazine sulfonamide portion of AMG 511Brian A. Lanman, Mark H. Norman, Anthony B. Reed et al.|Bioorganic & Medicinal Chemistry Letters|2014Cited by 4